# IITRI - NON-GLP DOSE RANGE FINDING (DRF) STUDIES-DEC. 2023 #2

> **NIH NIH N01** · IIT RESEARCH INSTITUTE · 2024 · $201,969

## Abstract

The National Institute of Neurological Disorders and Stroke (NINDS) and the NIH Blueprint Neurotherapeutics Network (BPN)
(http://neuroscienceblueprint.nih.gov/bpdrugs/index.htm) have established a ‘virtual pharma’ network of contract service providers and consultants with extensive industry experience to enable therapeutic (e.g., small molecule, peptide, biologic) development in the NIH research community. The Network and similar NINDS and NIH programs offer researchers access to a range of industry style
therapeutic development services and expertise, including medicinal chemistry, IND-enabling studies, and Phase I clinical trial infrastructure, with the goal of supporting efforts to advance compounds successfully through Phase I clinical testing.

## Key facts

- **NIH application ID:** 11212035
- **Project number:** 75N95021D00026-0-759502400004-1
- **Recipient organization:** IIT RESEARCH INSTITUTE
- **Principal Investigator:** MICHAEL O'RYAN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $201,969
- **Award type:** —
- **Project period:** 2024-07-22 → 2025-07-21

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11212035

## Citation

> US National Institutes of Health, RePORTER application 11212035, IITRI - NON-GLP DOSE RANGE FINDING (DRF) STUDIES-DEC. 2023 #2 (75N95021D00026-0-759502400004-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/11212035. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*